Navigation Links
PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors
Date:9/8/2008

nce, not including ClinPhone, was $260 to $270 million for the first quarter, and for the Fiscal Year was $1.125 to $1.155 billion.

As previously reported, the ClinPhone acquisition is expected to have a dilutive effect on earnings per share in the range of $0.04 to $0.06 for FY 2009, including the amortization of intangibles and other costs, with $0.01 to $0.02 cents of that amount being recorded in the first quarter. Excluding the amortization of intangibles and other costs, the acquisition is accretive. Beyond the impact from ClinPhone, the estimated negative impact of the recent sharp movements in foreign exchange rates on earnings per share has been essentially offset by somewhat better operating performance. As previously reported, the Company will also incur a one-time charge of approximately $0.02 cents per diluted share during the first quarter in conjunction with the write-off of unamortized loan fees and the unwinding of interest rate hedges related to the Company's previous credit line. Taking into account all of the afore-mentioned factors, PAREXEL now anticipates reporting diluted earnings per share on a GAAP basis in the range of $0.20 to $0.21 for the first quarter, and diluted earnings per share in the range of $1.09 to $1.17 for the Fiscal Year. Previously issued diluted earnings per share guidance, not including ClinPhone or the one-time charge, was in the range of $0.23 to $0.25 for the first quarter and in the range of $1.15 to $1.25 for the Fiscal Year.

A conference call to discuss PAREXEL's acquisition of ClinPhone and updated financial outlook will begin at 10:00 a.m. EDT tomorrow, Tuesday, September 9th and will be broadcast live over the Internet via webcast. The webcast may be accessed in the "Webcasts" portion of the Investor Relations section of the Company's website at http://www.PAREXEL.com. Users should follow the instructions provided to assure that the necessary audio
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
2. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
3. PAREXEL Closes the Acquisition of ClinPhone
4. PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
5. PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer
6. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2008 Earnings Release and Conference Call
7. PAREXEL International Updates Earnings Guidance in Conjunction with Its Investor Day
8. PAREXEL Expands Global Clinical Logistics Capabilities
9. Parexel Invites Public to Listen to Live Webcast of Its Investor Day June 25, 2008
10. PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
11. PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Look inside the new ... for the lab, from fluid handling to instruments to ... ship when you order. , Preferred Solutions features ... from the L/S® model for precise flow control and ...
(Date:1/15/2014)... This webinar will focus on EMA and ... in biosimilars. , Regulatory frameworks are evolving many countries ... the complex nature of biopharmaceuticals makes the demonstration of ... challenging. Based on the specific aspects of biosimilar drug ...
(Date:1/15/2014)... January 15, 2014 The Microcompetition with Foreign ... disease. One of these latent viruses is the Epstein Barr ... (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease that ... study found that RA patients have high concentrations of EBV ...
(Date:1/15/2014)... ON (PRWEB) January 15, 2014 AudioNotch ... experimental new therapy for the treatment of tinnitus. Patients ... tinnitus frequency, and over a period of weeks to months, ... Sound Therapy in two forms: Notched Music and Notched White ...
Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... for functional food partners and market entrance, ... Neptune Technologies &,Bioressources Inc. ("Neptune") (NASDAQ.NEPT - ... has been determined to be,safe as a ... for the,commercialization of NKO(R) incorporated into different ...
... after biological olfaction, the challenge has been to generate ... complexity to detect odors in the real world. A ... with exact chemical precision and reproducibility. , In a ... PLoS Biology, Joel White, Mary AtKisson, John Kauer and ...
... /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP), a ... discussing its,financial results for the fourth quarter and year ended December ... 2008 at 11:00 AM ET (8:00 ... Dial information is as follows: ...
Cached Biology Technology:Neptune Technologies receives GRAS notification in the United States 2Neptune Technologies receives GRAS notification in the United States 3Angiotech Pharmaceuticals, Inc. - Notice of Conference Call and Webcast 2
(Date:7/9/2014)... study co-authored by a University of Guelph scientist ... tags shows long-term exposure to a neonicotinoid pesticide ... The research by Nigel Raine, a professor in ... of Imperial College London was published July 9 ... Ecology . , The study shows how long-term ...
(Date:7/9/2014)... announce themselves with pain and fever but often can be ... are sneaky and hard to beat. Now, scientists have built ... tiny DNA pyramids. Published in the journal ACS Applied ... flag bacteria and kill more of them than medicine alone. ... infectious pathogens can lie in wait, undetectable in the human ...
(Date:7/9/2014)... A drug candidate developed by researchers at ... Sciences (NCATS) and its collaborators to treat ... Baxter International,s BioScience business. The drug candidate, ... target the underlying molecular mechanism of sickle ... clinical development activities required for regulatory approval ...
Breaking Biology News(10 mins):Bee foraging chronically impaired by pesticide exposure: Study 2First drug candidate from NIH program acquired by biopharmaceutical company 2First drug candidate from NIH program acquired by biopharmaceutical company 3First drug candidate from NIH program acquired by biopharmaceutical company 4
... University of Reading ,s Centre for Agri-Environmental Research, and funded ... Insect Pollinators Initiative Crops project, indicates that demand ... the number of colonies across Europe. The study, led ... colonies in 41 European countries with their demands for pollination ...
... Philadelphia, PA, January 9, 2014 Tobacco smoking by ... health risk because of smoking,s adverse effects on the ... is linked to numerous negative outcomes, including low birth ... attention deficit disorder, conduct disorder, and nicotine use in ...
... the School of Medicine at The University of Texas Health ... 31 for his discovery that a class of compounds is ... covers novel methods of preventing or treating neuronal damage, and ... based on this invention. Cell, animal and human ...
Cached Biology News:EU policy is driving up demand for pollination faster than honeybee numbers 2Maternal stress hormones and maternal smoking increase daughter's risk of nicotine dependence 2Discovery leads to patent for novel method of treating traumatic brain injury 2Discovery leads to patent for novel method of treating traumatic brain injury 3
... photographic filter (S37100, Photographic Filters for ... ideal for black-and-white photography of gels ... gel stain, the safer ethidium bromide ... photographic filter is identical to the ...
Mature rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and processed within 45 minutes. It is then filtered through gauze, pooled in an ...
LAL Chromogenic Endpoint assay...
uncoupling protein 2 (mitochondrial, proton carrier), mRNA (cDNA clone MGC:19567 IMAGE:4335185), complete cds...
Biology Products: